Business & Scientific Resources

The Innovative Medicines Initiative is providing funding for the development of therapeutics and diagnostics combatting coronavirus infections. 

The Medical CBRN Defense Consortium (MCDC) has created an OTA Consortium Portal to accelerate the DoD’s fielding of prototypes for medical countermeasures against COVID-19. 

The Medical Technology Enterprise Consortium (MTEC) is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities

This Notice is being provided to allow potential applicants sufficient time to develop responsive applications. 

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for projects focused on preclinical development of lead candidate therapeutics or vaccines (or related countermeasures) that address select NIAID Emerging Infectious Diseases/Pathogens

The newly launched Rapid Acceleration of Diagnostics (RADx) initiative will infuse funding into early innovative technologies to speed development of rapid and widely accessible COVID-19 testing.

The NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs.

NIDA is interested in research collecting on the risks for COVID-19 infection in individuals suffering from substance use disorders

NHLBI is issuing this NOSI to highlight the urgent need for research on Coronavirus and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 

NHLBI is issuing this NOSI to highlight the urgent need for research on COVID-19 and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 

NIAID and NIGMS are issuing this NOSI to highlight the urgent need for research on the coronavirus, particularly in projects focusing on viral natural history, pathogenicity, and transmission

NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19)